[1,2,4]triazolo[4,3-a]pyrazin-3-amine, 97%, 500mg

Cetyltrimethylammonium bromide (CTAB), 1 kg

1-(2-Chlorophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid, 97%, 100mg

3-(4-Amino-1-oxoisoindolin-2-yl)-1-methylpiperidine-2,6-dione, 98%, 100mg

4'-Bromo-4-phenylbutyrophenone, 97.0%, 1g

1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic acid, 95.0%, 5g

2-(6-Chloro-1H-indol-3-yl)acetonitrile, 95.0%, 1g

2-Amino-4-(4-cyclohexyl-phenyl)-thiophene-3-carboxylic acid methyl ester, 97%, 1g

4-Chlorobutyl benzoate, 97%, 100g

N-cyclopropylguanidine, 95.0%, 500mg

Ethyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate, 95.0%, 5g

D-gluconic acid calcium salt monohydrate, min. 98.5%, Ph. Eur., 2.5 kg, plastic packaging.

n-Butylaminopropyltrimethoxysilane, 2kg